Reuters logo
BRIEF-Furiex Pharma jumps in premarket after FDA ok's new drug treatments for type 2 diabetes
January 28, 2013 / 1:40 PM / in 5 years

BRIEF-Furiex Pharma jumps in premarket after FDA ok's new drug treatments for type 2 diabetes

NEW YORK, Jan 28 (Reuters) - Furiex Pharmaceuticals Inc : * Furiex Pharma jumps 34.2 percent to $28.50 in premarket after FDA OK’s new Takeda Pharmaceutical’s drug treatments for type 2 diabetes, resulting in milestone payments for Furiex

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below